WO1996012015A1 - Boucle d'arn/adn auto-stabilisante - Google Patents

Boucle d'arn/adn auto-stabilisante Download PDF

Info

Publication number
WO1996012015A1
WO1996012015A1 PCT/NL1995/000344 NL9500344W WO9612015A1 WO 1996012015 A1 WO1996012015 A1 WO 1996012015A1 NL 9500344 W NL9500344 W NL 9500344W WO 9612015 A1 WO9612015 A1 WO 9612015A1
Authority
WO
WIPO (PCT)
Prior art keywords
dna
gene
binding protein
rna
host
Prior art date
Application number
PCT/NL1995/000344
Other languages
English (en)
Inventor
Evert Hovius
Original Assignee
Evert Hovius
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evert Hovius filed Critical Evert Hovius
Priority to AU37550/95A priority Critical patent/AU3755095A/en
Publication of WO1996012015A1 publication Critical patent/WO1996012015A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli

Definitions

  • the SSL is formed by incorporating a DNA/RNA strand
  • prokaryotes or eukaryotes whereby a loop is formed consisting of a part of the DNA introduced and the inefficient operon or gene.
  • the loop is stabilized by a binding protein (to be examined further), the gene of which is located on the DNA strand introduced.
  • the positive regulator of the binding protein is located before the gene thereof.
  • the negative regulator inter alia together with the inefficient operon or gene, is excluded in the loop.
  • Located behind the gene of the binding protein are, respectively, a leader sequence, attenuator site, recognition sequence for the binding protein, negative regulator, attenuator site, leader sequence followed by a series of initiation signals.
  • the DNA/RNA strand is so composed as to specifically nestle before the inefficient operon or gene (or whatever it is desired to exclude in the loop), in that the stability of the total DNA is increased.
  • the manipulated DNA/RNA is situated in a protein coat the code of which does not occur on the DNA/RNA, as a result it cannot reproduce.
  • the concentration thereof must be as high as possible.
  • the lactose operon is mutated in one of the structural genes, then the proper form of the operon is incorporated into a manipulated virus (DNA/RNA strand) followed by a positive regulator gene A1.
  • the RNA polymerase starts the transcription on the lactose operon on the virus DNA. Thereafter the positive regulator gene A1 is transcribed, followed by the transcription of the binding gene B.
  • the binding gene B contains no normal termination site, but is followed by a leader sequence which contains two fantasy codons. As a result, the ribosomes stall, so that the leader messenger RNA passes a signal to the RNA polymerase to stop the transcription.
  • the RNA polymerase reaches the attenuator site and leaves the DNA here. Because the RNA polymerase leaves the DNA here, it does not reach the loop linked by the binding protein B.
  • RNA polymerase scans the DNA for
  • L leader sequence
  • the RNA polymerase falls off the virus DNA. (slide effect).
  • the attenuator site is followed by the
  • binding protein B binding protein B between two attenuator sites.

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Il s'agit d'un groupe de nouveaux médicaments d'origine génétique susceptibles de se substituer aux antibiotiques actuels, et constitués d'un ADN/ARN exempt de gène d'enveloppe et manipulé de telle manière qu'il se fixe dans une position spécifique et que, entre autres, il contient, dans l'ordre, les séquences suivantes: 1) l'opéron ou gène éventuellement à substituer; 2) un régulateur positif de la protéine de liaison; 3) le gène pour la protéine de liaison; 4) une séquence initiale; 5) un site atténuateur; 6) une séquence de reconnaissance pour la protéine de liaison; 7) un régulateur négatif pour la protéine de liaison; 8) un site atténuateur; 9) une séquence initiale; et 10) une séquence riche en initiation. Par conséquent, une boucle se forme dans l'ADN de l'hôte, cette boucle étant constituée d'une partie de l'ADN viral, à savoir les points 6, 7, 8, 9, 10, ainsi que l'opéron ou gène de l'hôte. L'ADN/ARN manipulé se situe dans une enveloppe protéique naturelle ou synthétique qui peut, suivant l'objectif envisagé, reconnaître un hôte.
PCT/NL1995/000344 1994-10-12 1995-10-10 Boucle d'arn/adn auto-stabilisante WO1996012015A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU37550/95A AU3755095A (en) 1994-10-12 1995-10-10 Self stabilizing rna/dna loop

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL9401678A NL9401678A (nl) 1994-10-12 1994-10-12 Methode van de zichzelf stabiliserende lus (Z.Z.S.L.).
NL9401678 1994-10-12

Publications (1)

Publication Number Publication Date
WO1996012015A1 true WO1996012015A1 (fr) 1996-04-25

Family

ID=19864761

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/NL1995/000344 WO1996012015A1 (fr) 1994-10-12 1995-10-10 Boucle d'arn/adn auto-stabilisante

Country Status (3)

Country Link
AU (1) AU3755095A (fr)
NL (1) NL9401678A (fr)
WO (1) WO1996012015A1 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2511033A1 (fr) * 1981-08-10 1983-02-11 Genex Corp Vecteurs d'expression permettant d'introduire un gene dans un organisme procaryote
WO1990000192A1 (fr) * 1988-07-01 1990-01-11 Genencor, Inc. Champignons filamenteux a carence de proteinase aspartique

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2511033A1 (fr) * 1981-08-10 1983-02-11 Genex Corp Vecteurs d'expression permettant d'introduire un gene dans un organisme procaryote
WO1990000192A1 (fr) * 1988-07-01 1990-01-11 Genencor, Inc. Champignons filamenteux a carence de proteinase aspartique

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
AMOUYAL EN VON WILCKEN-BERGMANN: "Repression of the E.coli lactose operon by cooperation between two individually unproductive "half-operator" sites", COMPTES RENDUS HEBDOMADAIRES DES SEANCES DE L'ACADEMIE DES SCIENCES, SERIE C: SCIENCES CHIMIQUES, vol. 315, MONTREUIL FR, pages 403 - 407 *

Also Published As

Publication number Publication date
AU3755095A (en) 1996-05-06
NL9401678A (nl) 1996-05-01

Similar Documents

Publication Publication Date Title
Grundy et al. Interaction between the acceptor end of tRNA and the T box stimulates antitermination in the Bacillus subtilis tyrS gene: a new role for the discriminator base
WO2001000843A3 (fr) Genes de corynebacterum glutamicum codant pour des proteines de voie metabolique
CN102428174A (zh) 工程再造mRNA一级结构以增强蛋白质产生
WO2001000844A3 (fr) Proteines codant pour les genes corynebacterium glutamicum, intervenant dans le metabolisme du carbone et dans la production d'energie
HUP0203340A2 (hu) Stressz-, rezisztencia- és toleranciafehérjéket kódoló Corynebacterium glutamicum gének
WO2001000842A3 (fr) Genes de corynebacterium glutamicum codant des proteines impliquees dans l'homeostase et adaptation
AU2390301A (en) Corynebacterium glutamicum genes encoding metabolic pathway proteins
WO2001002583A3 (fr) Genes de corynebacterium glutamicum codant pour des proteines du systeme de transport des sucres phosphotransferase: phosphoenolpyruvate
HU0004168D0 (fr)
EP0139501A3 (fr) Production et expression de gènes pour thaumatine
WO1996012015A1 (fr) Boucle d'arn/adn auto-stabilisante
CA2037677A1 (fr) Methode de production d'un gene exogene ou son produit dans les cellules vegetales
TR200003272T2 (tr) Protein üretimi verilmesi için G-CSF geninin genomik sekanslar.
Messer Initiation of DNA replication in Escherichia coli
WO2003048325A3 (fr) Sequences nucleotidiques de promoteurs de la beta-actine et de l'actine issus de crevettes et leur utilisation en genie genetique
CN104404069B (zh) 一种低拷贝pTerm质粒及其构建方法和应用
Lengyel The process of translation as seen in 1969
CA2062095A1 (fr) Methode pour la manipulation genetique de myxobacteries
Martin et al. Redesigning cells for production of complex organic molecules
WO2002022799A3 (fr) Procede de production microbienne de metabolites, polynucleotides de bacteries coryneformes et leur utilisation
CN1756840B (zh) 诱导体细胞同源重组的方法
WO2002008424A1 (fr) Genes abca2 humain et de rat
Crosby REGULATION OF THE DROSOPHILA GLUE GENE SGS-3: SEQUENCES REQUIRED FOR PUFFING AND TRANSCRIPTION (LETHAL MUTATIONS, 68AC REGION)
EP1634952A3 (fr) Gènes codants pour des protéines de Corynebacterium glutamicum, qui participent à l'homéostasie et à l'adaptation
EP1683859A3 (fr) Eventuel gène codant pour Catechol 1,2-Dioxygenase de Corynebacterium glutamicum

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TT UA UG US UZ VN

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): KE MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: CA